Table 1 The differentially expressed HOX genes in association with head and neck squamous cell carcinoma.
DEHGs | Genes |
|---|---|
Upregulated | HOXA9, HOXA10, HOXA11, HOXB7, HOXB9, HOXB13, HOXC4, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXD1, HOXD10, HOXD11, HOXD13 |
Differentially methylated | HOXA9, HOXA10, HOXA11, HOXB7, HOXB13, HOXC8, HOXC9, HOXD10, HOXD13 |
Hypermethylated genes | HOXD10 |
Inverse correlation—Gene expression and methylation | HOXA9, HOXA10, HOXB7, HOXB13, HOXC9 |
Positive correlation—Gene expression and methylation | HOXD10 |
SNVs | Missense mutation: HOXA11, HOXB7, HOXB13, HOXC4, HOXC6, HOXC8, HOXC9, HOXC10, HOXD10, HOXD13 Non-sense mutation: HOXB7 In-frame deletion: HOXD13 |
CNVs | HOXA9, HOXA10, HOXA11, HOXB7, HOXB9, HOXB13, HOXC4, HOXC5, HOXC6, HOXC8, HOXC9, HOXC10, HOXD1, HOXD10, HOXD11, HOXD13 |
Associated with HPV infection | DE between HPV- positive and HPV-negative tumors: HOXB13, HOXC5, HOXC6, HOXC9 and HOXD11 |
Cancer staging | Stage 1 versus stage 4: HOXA10, HOXB9, and HOXC8 Stage 2 versus stage 4: HOXC4 All the stages: HOXD1 |
Survival status | OS- HOXC5, HOXC6, HOXB9 DFS- HOXC8 |